Medi-Weightloss Review
Best for: Patients wanting in-person physician-supervised GLP-1 care with insurance/HSA use
Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth. Its GLP-1 program prescribes branded Wegovy and Zepbound as well as compounded semaglutide and compounded tirzepatide, alongside older agents like phentermine. Programs are evidence-based, with body-composition analysis and personalized plans. A new-patient visit runs about $199 and includes a medical assessment, labs and GLP-1 eligibility review; ongoing medication costs depend on the plan. Insurance is accepted at many locations and HSA/FSA accounts are welcome.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Medi-Weightloss is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Medi-Weightloss prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| New patient visit | brand | $199 |
✓ Pros
- •Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
- •Established brand with 130+ physician-supervised locations nationwide
- •Telehealth plus in-person clinic options
- •Accepts insurance at many locations; HSA/FSA welcome
- •Includes body-composition analysis and personalized plans
✗ Cons
- •Ongoing medication pricing not transparently posted; varies by plan
- •$199 new-patient visit fee before medication costs
- •Frequent (often weekly) visits expected for some patients
- •Compounded products are not FDA-approved or evaluated
Ready to start with Medi-Weightloss?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our Medi-Weightloss review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Medi-Weightloss
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Medi-Weightloss?
Starting at $199/month. See current pricing and start your free consultation.